{
    "code": 0,
    "data": [
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Q3 & 9M FY26 Earning Conference Call Transcript",
            "news_id": "b05c5b37-a7e4-48f5-a671-278180290709",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=12526510-623f-4c1d-8698-a5cd5f755758.pdf",
            "news_date": "2026-02-10 20:46:38",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Q3 & 9M FY26 Earning Conference Call Transcript",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=12526510-623f-4c1d-8698-a5cd5f755758.pdf",
            "news_date": "2026-02-10 20:46:38"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Publication of Financial Results",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=264496ee-9503-4e4e-bcf9-3c12d51be001.pdf",
            "news_date": "2026-02-05 18:57:38"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of Investors Conference",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=514dd583-8b0e-424e-8c15-d1fc3d61c57e.pdf",
            "news_date": "2026-02-04 19:13:14"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of Investors Conference",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b844f29f-62de-4230-bd93-733b3302601f.pdf",
            "news_date": "2026-02-04 19:09:26"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Recording of earning conference call",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8039ae0c-fa02-491f-94c0-6924f09b94fb.pdf",
            "news_date": "2026-02-04 19:04:03"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Q3 & 9M FY26 Business & Financial Performance",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7676ca25-b7ae-4de2-934c-58b4b8ca4cdd.pdf",
            "news_date": "2026-02-03 20:07:52"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Q3 & 9M FY26 Investor Presentation",
            "news_id": "e1725ad3-e131-48b4-857e-71beff7cf44a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5a8d8db7-2785-4ce0-82c9-154468f69abb.pdf",
            "news_date": "2026-02-03 20:01:47",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Q3 & 9M FY26 Investor Presentation",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5a8d8db7-2785-4ce0-82c9-154468f69abb.pdf",
            "news_date": "2026-02-03 20:01:47"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Please find our intimation in captioned subject",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=89b5feac-48cf-4c67-ab6f-ef0af00bddbd.pdf",
            "news_date": "2026-02-03 19:36:48"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "Intimation",
            "descriptor": "Record Date",
            "caption": "Record Date For Interim Dividend",
            "news_body": "Record date for interim dividend",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=db71433e-3a76-458f-8fd0-a5d1eb1c1fef.pdf",
            "news_date": "2026-02-03 19:27:22"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "Outcome",
            "descriptor": "Dividend",
            "caption": "Corporate Action-Board approves Dividend",
            "news_body": "Board approves Interim Dividend",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1ce135e3-2aaf-4003-a64e-c0ae991dbf80.pdf",
            "news_date": "2026-02-03 19:24:19"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "Outcome of Board meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bbc86e0c-6968-4b29-b2b2-84eb279872bd.pdf",
            "news_date": "2026-02-03 19:02:03"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financials Results For The Quarter And Nine Months Ended December 31 2025",
            "news_body": "Financial Results for the quarter and nine months ended December 31 2025",
            "news_id": "51164847-41e2-4fcc-9a1e-12c9bfec351f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=06b881ec-e0b0-44db-a760-96791d3a1c50.pdf",
            "news_date": "2026-02-03 18:55:59",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Financials Results For The Quarter And Nine Months Ended December 31 2025",
            "news_body": "Financial Results for the quarter and nine months ended December 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=06b881ec-e0b0-44db-a760-96791d3a1c50.pdf",
            "news_date": "2026-02-03 18:55:59"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Credit Rating",
            "caption": "Announcement under Regulation 30 (LODR)-Credit Rating",
            "news_body": "Credit rating",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a0409763-256a-4e8d-a1db-f8c625aee399.pdf",
            "news_date": "2026-01-29 20:14:24"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of Quarterly Earning Conference Call for Q3 FY26",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3abb666b-ba17-4c1f-af35-cc685fb5c87a.pdf",
            "news_date": "2026-01-28 21:44:24"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Audited Financial Results For The Quarter And Nine Months Ended December 31 2025 And Interim Dividend For The FY 2025-26 If Any",
            "news_body": "Aarti Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2026 inter alia to consider and approve Audited financial results for the quarter and nine months ended December 31 2025 and Interim Dividend for the FY 2025-26 if any",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=24885b47-bc78-499d-a3c9-0462ce7d2730.pdf",
            "news_date": "2026-01-27 17:44:15"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Certificate under Reg. 74(5) of SEBI (DP) Regulations 2018",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e6d25ad2-5f70-4539-b323-1c6fddca0c7c.pdf",
            "news_date": "2026-01-07 19:02:11"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "The Trading Window of the Company will remain closed from January 1 2026 until the expiry of 48 hours after the declaration of financial results for the quarter and nine months ended December 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=67615fdd-efff-4b7e-a541-3688b40e968b.pdf",
            "news_date": "2025-12-29 18:34:11"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Intimation about Newspaper Publication regarding Special Window for re-lodgement of transfer requests of physical shares.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=33a21ba5-25ce-480d-90a9-d452d78de0ff.pdf",
            "news_date": "2025-11-18 19:34:33"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Q2 & H1 FY26 Earning Conference Call Transcript",
            "news_id": "92538321-f770-44f8-aec9-a77977733332",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1be6f5fc-e6b7-4807-832c-63ac97f90a7d.pdf",
            "news_date": "2025-11-14 18:46:33",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Q2 & H1 FY26 Earning Conference Call Transcript",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1be6f5fc-e6b7-4807-832c-63ac97f90a7d.pdf",
            "news_date": "2025-11-14 18:46:33"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Recording of Conference Call",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9869961a-702e-4fb0-983d-c17cd6b70091.pdf",
            "news_date": "2025-11-10 22:22:26"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper advertisement of financial results for the quarter and half year ended September 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6a88f0e6-c1fb-4fa5-a9c1-e386a965dde6.pdf",
            "news_date": "2025-11-08 21:00:13"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Q2 and H1 FY 26 Investor Presentation",
            "news_id": "81abe44e-ba0c-43ad-98b2-208c0616aed4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d2f24fc5-1403-4507-8511-5a45fb18ff06.pdf",
            "news_date": "2025-11-07 20:45:13",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Q2 and H1 FY 26 Investor Presentation",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d2f24fc5-1403-4507-8511-5a45fb18ff06.pdf",
            "news_date": "2025-11-07 20:45:13"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press Release - Q2 & H1 FY26 Business and Financial Performance",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ffb29c1b-df29-4626-a1a8-7c2399bef2ca.pdf",
            "news_date": "2025-11-07 20:39:16"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Financial Results For The Quarter And Half Year Ended September 30 2025",
            "news_body": "Financial Results for the quarter and half year ended September 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ff9756a1-7d7c-4437-a0d7-61b804e4a424.pdf",
            "news_date": "2025-11-07 14:55:53"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter And Half Year Ended September 30 2025",
            "news_body": "Financial Results for the quarter and half year ended September 30 2025",
            "news_id": "77690fd1-fd9b-407e-9e37-acc52fe7f837",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0706d35f-c912-49aa-a306-222baa4dc32f.pdf",
            "news_date": "2025-11-07 14:48:30",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Financial Results For The Quarter And Half Year Ended September 30 2025",
            "news_body": "Financial Results for the quarter and half year ended September 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0706d35f-c912-49aa-a306-222baa4dc32f.pdf",
            "news_date": "2025-11-07 14:48:30"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of Quarterly Earning Call",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e8b6dbc5-a6fe-408e-8f96-29dedfc15f36.pdf",
            "news_date": "2025-10-31 20:37:03"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Audited Financial Results For The Quarter And Half Year Ended September 30 2025",
            "news_body": "Aarti Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2025 inter alia to consider and approve Audited Financial Results for the quarter and half year ended September 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cec22b94-6375-468c-8028-3a5ea12a837b.pdf",
            "news_date": "2025-10-31 20:25:58"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Crisil ESG Rating",
            "news_body": "Intimation under regulation 30 of SEBI (LODR) 2015 - Crisil ESG Rating",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=69073b1a-f9eb-43ad-9118-ff3ca1cf4b1c.pdf",
            "news_date": "2025-10-09 19:03:41"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b6cf98cb-5caa-4bca-8eb0-53f802a0779d.pdf",
            "news_date": "2025-10-08 18:33:50"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (\"Listing Regulations\")",
            "news_body": "Disclosure under Regulation 30 of SEBI Listing Regulations",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c985a9cf-84aa-4699-a53c-2d9fdfbd1cc6.pdf",
            "news_date": "2025-10-06 23:44:48"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Closure of trading window",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e3aac753-0619-441a-80bb-020622f6067a.pdf",
            "news_date": "2025-09-29 22:56:42"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "Outcome",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
            "news_body": "Please find attached Scrutinizers Report along with Voting results pursuant to Regulation 44 of Listing Regulation",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=57f19bee-a4a5-4abc-8717-efc300b83a76.pdf",
            "news_date": "2025-09-24 20:58:01"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Re-appointment of Director liable to retire by rotation and appointment of Secretarial Auditor at AGM",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=afb0cf75-ad7f-4201-9a12-1fdd3a200662.pdf",
            "news_date": "2025-09-24 20:48:58"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find attached presentation made to the shareholders at 40th AGM",
            "news_id": "28b1d18a-747f-40a1-81d1-5e0fce7b01d8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8408530c-9a97-4c86-85e6-fe7ffbfdb4e9.pdf",
            "news_date": "2025-09-24 20:35:14",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find attached presentation made to the shareholders at 40th AGM",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8408530c-9a97-4c86-85e6-fe7ffbfdb4e9.pdf",
            "news_date": "2025-09-24 20:35:14"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "Outcome",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Outcome of AGM",
            "news_body": "Please find attached herewith proceedings of 40th AGM of the Company held through VC/ OAVM",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2188fa1f-7896-449f-9125-5e97e522cadd.pdf",
            "news_date": "2025-09-24 20:27:19"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Closure Of Chlorosulfonation Process At PTSCL Section At T-150 Unit Pursuant To Voluntary Closure Directions Of MPCB",
            "news_body": "Closure of chlorosulfonation process at PTSCL section at T-150 unit pursuant to Voluntary Closure Directions of MPCB",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fa38a02d-0538-43f7-8478-1250d68faa3e.pdf",
            "news_date": "2025-09-10 14:35:39"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Commercialization Of Manufacturing Plant Located At Sayakha",
            "news_body": "Commercialization of manufacturing plant located at Sayakha",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b38c5cc9-2002-4675-861c-7eb527e35afe.pdf",
            "news_date": "2025-09-04 19:05:38"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Intimation of Newspaper advertisement regarding completion of dispatch of Annual Report for FY 2024-25 and notice of 40th Annual General Meeting of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=795ff735-a917-4bca-9458-9e73de19c233.pdf",
            "news_date": "2025-09-02 19:20:29"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Intimation of newspaper advertisement regarding completion of dispatch of Annual Report for FY 2024-25 and Notice of 40th AGM of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=11f8eff5-5110-4d80-b90b-d19bccbd7efb.pdf",
            "news_date": "2025-09-01 19:51:18"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Business Responsibility and Sustainability Reporting (BRSR)",
            "caption": "Business Responsibility and Sustainability Reporting (BRSR)",
            "news_body": "Please find attached BRSR for FY 2024-25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=08d66d37-7ffd-42a1-8b18-8dc84cb78a50.pdf",
            "news_date": "2025-08-30 22:47:14"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "Intimation",
            "descriptor": "AGM",
            "caption": "Notice Of 40Th Annual General Meeting",
            "news_body": "Please find attached herewith Annual Report For FY 2024-25 including Notice of 40th Annual General Meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=01cbce30-fa21-450f-a96c-83e0f3bf75c7.pdf",
            "news_date": "2025-08-30 22:39:48"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Reg. 34 (1) Annual Report",
            "caption": "Reg. 34 (1) Annual Report.",
            "news_body": "Annual Report for FY 2024-25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8fbfe419-cd84-4ea7-9e7c-9ff3639620bb.pdf",
            "news_date": "2025-08-30 22:27:10"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Intimation of newspape advertisement regarding 40th Annual General Meeting of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a72da5d6-92d4-44dc-890b-c7de713dd718.pdf",
            "news_date": "2025-08-29 18:55:08"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Publication of 100 days Campaign - Saksham Niveshak",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=92e02ec6-56de-45d3-b495-e8f1fc1a4b66.pdf",
            "news_date": "2025-08-22 23:46:37"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press Release on 100 days Campaign - Saksham Niveshak",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bc60a1f2-374d-428b-98ce-227aec01838e.pdf",
            "news_date": "2025-08-21 16:29:42"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper publication regarding special window for re-lodgement of transfer request of physical shares",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4d37f6f9-1f1b-4f91-94ef-d322a6f8bc72.pdf",
            "news_date": "2025-08-16 19:46:50"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of Schedule of Analyst Meet",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=67ff6594-bf6e-4904-9ad6-0669920fa01b.pdf",
            "news_date": "2025-08-06 19:26:07"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of Schedule of Analyst Meet",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0a276f9b-e586-4806-8c3f-2e4745dcbcec.pdf",
            "news_date": "2025-08-06 19:18:50"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Q1FY26 Earning Conference Call",
            "news_id": "c25661e9-e5bd-4153-bd4c-acc1cd139c1e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=713d4b40-7c37-46a7-8a00-3cbb42308964.pdf",
            "news_date": "2025-07-25 23:04:56",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Q1FY26 Earning Conference Call",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=713d4b40-7c37-46a7-8a00-3cbb42308964.pdf",
            "news_date": "2025-07-25 23:04:56"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Recording of earning conference call for the quarter ended June 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f6623041-2c9e-474f-b5b2-b453fa0dde2d.pdf",
            "news_date": "2025-07-21 18:56:02"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Publication of Q1FY26 financial results",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1baacac8-5808-4418-8bf1-8b6edcf7adf0.pdf",
            "news_date": "2025-07-19 18:14:45"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Q1FY26 Investor Presentation",
            "news_id": "e65d58ee-b99e-4e76-aba3-8de230809dc8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=31508af2-3857-41d0-87c6-11cc757f16df.pdf",
            "news_date": "2025-07-19 18:08:56",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Q1FY26 Investor Presentation",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=31508af2-3857-41d0-87c6-11cc757f16df.pdf",
            "news_date": "2025-07-19 18:08:56"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press Release on financial results for the quarter ended June 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c162e6f4-c5b5-4466-8537-f22ac727225e.pdf",
            "news_date": "2025-07-18 22:33:24"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Appointment Of Secretarial Auditor",
            "news_body": "Appointment of Secretarial Auditor",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=56f35075-da0f-4986-b099-9cabf97a766d.pdf",
            "news_date": "2025-07-18 17:05:56"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Audited Standalone And Consolidated Financial Results For The Quarter Ended June 30 2025 And Outcome Of The Meeting Of The Board Of Directors Held On July 18 2025",
            "news_body": "Audited Standalone and Consolidated Financial Results for the Quarter ended June 30 2025 and Outcome of the Meeting of the Board of Directors held on July 18 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=694e04fa-c224-44a5-848e-86f6275bf76d.pdf",
            "news_date": "2025-07-18 16:45:17"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter Ended June 30 2025",
            "news_body": "Financial Results for the quarter ended June 30 2025",
            "news_id": "b84f716e-98ce-4d0a-a073-31e4d76f2c08",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8d21b39c-a847-4d03-a99c-732102d5beb2.pdf",
            "news_date": "2025-07-18 16:40:52",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Financial Results For The Quarter Ended June 30 2025",
            "news_body": "Financial Results for the quarter ended June 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8d21b39c-a847-4d03-a99c-732102d5beb2.pdf",
            "news_date": "2025-07-18 16:40:52"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Reply To The Clarification Sought With Respect To Increase In The Volume Of Security Across The Exchange",
            "news_body": "Reply to the clarification sought with respect to increase in the volume of security across the exchange.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8c9f9382-13e8-4359-adc1-f06036614d26.pdf",
            "news_date": "2025-07-16 14:23:27"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "General",
            "descriptor": "Clarification",
            "caption": "Clarification sought from Aarti Drugs Ltd",
            "news_body": "The Exchange has sought clarification from Aarti Drugs Ltd on July 16 2025 with reference to Movement in Volume. <BR><BR>The reply is awaited.",
            "file_url": "",
            "news_date": "2025-07-16 12:39:16"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of earning conference call",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3d26e698-f239-4d42-8471-d8f07e0f53a5.pdf",
            "news_date": "2025-07-15 19:10:57"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Audited Financial Results For The Quarter Ended June 30 2025.",
            "news_body": "Aarti Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/07/2025 inter alia to consider and approve Audited financial results for the quarter ended June 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0ae10dd4-329d-4f23-8eb6-452f2b3aee59.pdf",
            "news_date": "2025-07-15 18:57:12"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7eafb336-6cc0-4e34-ab67-48a01f4f511a.pdf",
            "news_date": "2025-07-12 11:54:09"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation of Closure of Trading Window",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e04734e7-95be-4151-949d-d3c4eeb7cee1.pdf",
            "news_date": "2025-06-27 14:09:44"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Submission of notice to equity shareholders regarding transfer of equity shares to IEPF Account",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=25e72b8a-2794-4aaa-a605-6e2ffa96d1ba.pdf",
            "news_date": "2025-06-14 18:36:19"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "Compliance",
            "descriptor": "Reg.24(A)-Annual Secretarial Compliance",
            "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
            "news_body": "Annual Secretarial Compliance Report for the year ended March 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f7fce9c0-6c94-4c91-a72e-49e4fafde0e0.pdf",
            "news_date": "2025-05-28 16:01:44"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of Schedule of Analyst Meet",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2161eb97-c76c-4e06-90eb-ae099416406c.pdf",
            "news_date": "2025-05-22 18:36:07"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Q4FY25 Earning concall transcript",
            "news_id": "303b7f83-d9ae-4e4f-a7ea-15e269371536",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=617079fa-ec10-423d-9928-f7d3d1819bf9.pdf",
            "news_date": "2025-05-12 23:59:55",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Q4FY25 Earning concall transcript",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=617079fa-ec10-423d-9928-f7d3d1819bf9.pdf",
            "news_date": "2025-05-12 23:59:55"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper publication of financial results for the quarter and year ended March 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=857584db-fc5a-437b-939b-910592bd093f.pdf",
            "news_date": "2025-05-08 23:53:26"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Recording of Conference Call on the financial results for the quarter and year ended March 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2920359f-458f-42a3-82dd-5492db81280a.pdf",
            "news_date": "2025-05-07 18:51:14"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30 - Ad-Interim Order By The Court",
            "news_body": "Disclosure under Regulation 30- ad-interim order by the court",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f790d2a3-1c42-49b8-9b2f-dfcd04610193.pdf",
            "news_date": "2025-05-07 00:44:39"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Q4 & FY25 Investor Presentation",
            "news_id": "97595396-9e53-42b8-b00a-8d651c9653e2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0b0903a9-7c4f-4bd6-aa65-ad7f91519bc7.pdf",
            "news_date": "2025-05-06 18:59:57",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Q4 & FY25 Investor Presentation",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0b0903a9-7c4f-4bd6-aa65-ad7f91519bc7.pdf",
            "news_date": "2025-05-06 18:59:57"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press Release \"Q4 and FY25 Business & Financial Performance\"",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0b7d4b2b-ae32-4fe9-a834-b4b476a0018a.pdf",
            "news_date": "2025-05-06 18:55:45"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Financial Results For The Quarter And Year Ended March 31 2025 And Appointment Of Cost Auditor",
            "news_body": "Financial Results for the quarter and year ended March 31 2025 and appointment of Cost Auditor",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e1bb7b05-b2de-4cb6-a9a2-4038121ae5f6.pdf",
            "news_date": "2025-05-06 16:26:47"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting And Financial Results For The Quarter And Year Ended March 31 2025",
            "news_body": "Outcome of the Board meeting and Financial Results for the quarter and year ended March 31 2025",
            "news_id": "a5c2fa1b-5c01-4e81-82b0-f0b1339101b5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8cbe7063-7486-4b1f-b49a-bef6526dce95.pdf",
            "news_date": "2025-05-06 16:23:54",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Outcome Of The Board Meeting And Financial Results For The Quarter And Year Ended March 31 2025",
            "news_body": "Outcome of the Board meeting and Financial Results for the quarter and year ended March 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8cbe7063-7486-4b1f-b49a-bef6526dce95.pdf",
            "news_date": "2025-05-06 16:23:54"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of Quarterly Earning Conference Call",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=84057dd7-9011-4ef4-952a-764f2b68fb02.pdf",
            "news_date": "2025-04-29 22:43:26"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Audited Financial Results For The Quarter And Year Ended March 31 2025",
            "news_body": "Aarti Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/05/2025 inter alia to consider and approve Audited Financial Results for the Quarter and year ended March 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d2df08e2-113e-40aa-9e3b-48ad7d81e895.pdf",
            "news_date": "2025-04-29 19:19:07"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Certificate under Re. 74(5) of SEBI (DP) Regulations 2018",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b8760bc3-e59c-4ba4-9f77-c8f342f1d0fa.pdf",
            "news_date": "2025-04-08 11:43:02"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30 Of SEBI Listing Regulations",
            "news_body": "Disclosure under Regulation 30 of SEBI Listing Regulations - Cautionary letter from Stock Exchange.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=02ecd19f-5403-4104-ade1-aaceeb487ed3.pdf",
            "news_date": "2025-04-02 15:53:20"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Intimation of Closure of Trading Window",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7df5c3cb-cc58-4a28-9851-97811f98a61a.pdf",
            "news_date": "2025-03-29 14:47:01"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "General",
            "descriptor": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
            "news_body": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for DSP Trustee Pvt Ltd & Others",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=AC2292EA_FD54_48EC_B2BF_DA5B081DEF88_095158.pdf",
            "news_date": "2025-03-26 09:52:07"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of Schedule of Analyst / Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=631b25d1-7835-4c8f-87e6-bb6334ef6907.pdf",
            "news_date": "2025-03-17 18:09:18"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Cancellation of Schedule of Analyst / Institutional Investor Meetings.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3815e664-de25-43d0-b3b5-e3770c804377.pdf",
            "news_date": "2025-03-11 19:36:26"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (\"Listing Regulations\")",
            "news_body": "Announcement under Regulation 30 of the SEBI (LODR) Regulations 2015",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=25b64189-d05d-4e90-8de1-26bf446f8f6e.pdf",
            "news_date": "2025-03-07 12:45:56"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (\"Listing Regulations\") - Action Taken Or Order Passed",
            "news_body": "Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 (Listing Regulations) - Action taken or Order Passed",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bc571a63-aa9b-4497-94eb-813879d68ba4.pdf",
            "news_date": "2025-03-06 20:19:48"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Announcement Under Regulation 30 Of Listing Regulations - ESG Rating",
            "news_body": "Announcement under Regulation 30 of Listing Regulation - ESG Rating",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=316a398a-5ba9-4606-bcbb-d3be0489a7bf.pdf",
            "news_date": "2025-03-03 19:39:54"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of Schedule of Analyst / Institutional Investor Meetings",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=25a7c25b-45da-4a85-ac95-9417894403ce.pdf",
            "news_date": "2025-02-28 18:25:04"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Reg 30 Of Listing Regulations - Update On Lifting Of Import Alert 66-40 By US DFA",
            "news_body": "Disclosure under Reg 30 of Listing Regulations - Update on lifting of Import Alert 66-40 by US FDA",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cbfabfcc-cee1-45c7-a56d-747cde571dcb.pdf",
            "news_date": "2025-02-14 15:10:13"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30 Of Listing Reguations- Order Of CGST And C.Ex. Authority",
            "news_body": "Disclosure under Regulation 30 of Listing Regulations - Order of CGST and C.Ex. Authority",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=50cdb4be-c7e1-4500-b7aa-79e72c7809fa.pdf",
            "news_date": "2025-02-07 20:09:15"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30 Of Listing Regulations-",
            "news_body": "Disclosure under Regulation 30 of Listing Regulations",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0baac90e-4c89-4392-a4c1-b2506e91b07d.pdf",
            "news_date": "2025-02-05 21:48:22"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Q3FY25 Earnings call transcript",
            "news_id": "142a8fe9-f68c-4be4-9b2e-238a8b742c2d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=43f4aa71-65b7-489e-9d31-e79810448d7f.pdf",
            "news_date": "2025-02-04 22:25:45",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Q3FY25 Earnings call transcript",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=43f4aa71-65b7-489e-9d31-e79810448d7f.pdf",
            "news_date": "2025-02-04 22:25:45"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Acquisition",
            "caption": "Announcement under Regulation 30 (LODR)-Acquisition",
            "news_body": "Announcement dated February 3 2025 regarding Disclosure under Regulation 30 of Listing Regulations",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=06243da0-92a6-4f31-a8d0-556eb8ca9992.pdf",
            "news_date": "2025-02-04 15:04:27"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Acquisition",
            "caption": "Announcement under Regulation 30 (LODR)-Acquisition",
            "news_body": "Entering into Share Subscription and Shareholders Agreement for Power Purchase",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=958011b3-4996-4b46-9697-92409ddc6988.pdf",
            "news_date": "2025-02-03 15:37:23"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Publication",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=44e9d88e-7891-44c7-a853-599147b6362e.pdf",
            "news_date": "2025-01-31 18:14:53"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Credit Rating",
            "caption": "Announcement under Regulation 30 (LODR)-Credit Rating",
            "news_body": "Credit Rating",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0de2f7cb-e795-4fb8-a2f8-12d931e8b05c.pdf",
            "news_date": "2025-01-31 13:49:19"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Reconding of Conference Call",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f0b4753a-e4a2-41b2-a748-a512cfa30c80.pdf",
            "news_date": "2025-01-30 18:41:17"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Q3 & 9M FY25 Investor Presentation",
            "news_id": "c6c547fe-79d9-41e7-b0f2-ae54e4a84bae",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=66ba3057-031b-4784-ab65-4476425adc62.pdf",
            "news_date": "2025-01-29 21:13:59",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Q3 & 9M FY25 Investor Presentation",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=66ba3057-031b-4784-ab65-4476425adc62.pdf",
            "news_date": "2025-01-29 21:13:59"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press release on Q3 & 9M FY25 Business and Financial Performance",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8373e52d-f19e-4a89-82af-40c5ec696083.pdf",
            "news_date": "2025-01-29 21:09:58"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Acquisition",
            "caption": "Announcement under Regulation 30 (LODR)-Acquisition",
            "news_body": "Investment in Pinnacle Life Science Private Limited Wholly Owned Subsidiary of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5a397419-2506-4d18-a9b1-072b0ea0876e.pdf",
            "news_date": "2025-01-29 20:43:49"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "General_Announcements",
            "descriptor": "Integrated Filing (Financial)",
            "caption": "Integrated Filing (Financial)",
            "news_body": "Integrated filing (financial) for the quarter ended December 31 2024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2b3165c2-9c77-43d3-be56-4f8840d70cc5.pdf",
            "news_date": "2025-01-29 20:32:45"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "Intimation",
            "descriptor": "Record Date",
            "caption": "Record Date For Interim Dividend",
            "news_body": "Record date for Interim Dividend",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=daa452c6-f214-4453-8859-d212e121a54e.pdf",
            "news_date": "2025-01-29 17:34:25"
        },
        {
            "co_code": 2975,
            "bse_code": 524348,
            "isin": "INE767A01016",
            "ann_type": "Outcome",
            "descriptor": "Dividend",
            "caption": "Corporate Action-Board approves Dividend",
            "news_body": "Board approved the Interim Dividend",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=29329a4b-1c8c-4bc8-8b39-10a57f59f215.pdf",
            "news_date": "2025-01-29 17:32:13"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter And Nine Months Ended December 31 2024 And Interim Dividend",
            "news_body": "Financial Resuls for the quarter and nine months ended December 31 2024 and Interim dividend",
            "news_id": "3ee3460d-19fb-4982-bc18-bb3ef5fad5a4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c7fc2977-e25b-4eb8-8841-a3d69eb72274.pdf",
            "news_date": "2025-01-29 16:41:14",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Q2FY25 Earning call",
            "news_id": "86118c0f-5505-4347-9bd7-47c1154f7eb1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6fdf1955-f801-4102-86fd-a76096a0ec66.pdf",
            "news_date": "2024-11-02 19:10:29",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Q2 and FY25 Investor Presentation",
            "news_id": "ddfc64e4-f70a-488a-b46e-8322bd6718c3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4cd31747-68a5-4f62-9b2b-5ef3e68208d1.pdf",
            "news_date": "2024-10-24 21:28:51",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter And Half Year Ended September 30, 2024",
            "news_body": "Financial Results for the quarter and half year ended September 30, 2024",
            "news_id": "b9732165-72d9-4be2-b4b2-ff412e09ee4c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=83654e8a-1c51-4d42-9686-09692520120d.pdf",
            "news_date": "2024-10-24 18:04:42",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Presentation made to the shareholders at the 39th AGM",
            "news_id": "ed5c2ab8-6da8-4409-a04e-c59cc6e181f9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=abdd4481-cae9-423f-8863-9ba3db07a974.pdf",
            "news_date": "2024-09-20 19:56:00",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Q1FY25 earning conference call",
            "news_id": "3f3fc2e5-632a-4a8c-ad83-87032d5439be",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9d8f4ed0-30e9-42c7-85e2-fd8c3aa1ef5b.pdf",
            "news_date": "2024-08-05 18:14:35",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Q1FY25 Investor Presentation",
            "news_id": "ff8adb6f-2e9a-44f5-81cd-7f5d96f9ef2c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=042a25ed-6198-4627-9438-0f308a6829f3.pdf",
            "news_date": "2024-07-26 19:32:17",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter Ended June 30, 2024",
            "news_body": "Financial Results for the quarter ended June 30, 2024",
            "news_id": "c464a17c-6116-4278-a166-75dcadec2e98",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d742fc3c-a4ca-400b-81b8-2f9d2ea5284f.pdf",
            "news_date": "2024-07-26 17:34:33",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Q4 FY 24 earning call transcript.",
            "news_id": "16ca7d34-b374-4109-bb2e-5c3a345ecb95",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=be128bae-e8ea-4eb9-9074-e07afaf24f88.pdf",
            "news_date": "2024-05-10 19:59:01",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for the Quater and Year ended March 31, 2024.",
            "news_id": "cfab4070-77e4-4048-aa75-df1b2d157ee7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=38b37233-9605-4055-a607-f93fc9fc1d2a.pdf",
            "news_date": "2024-05-04 18:17:43",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Standalone And Consolidated Financial Results For The Quarter And Year Ended March 31, 2024",
            "news_body": "Financial Results for the quarter and year ended March 31, 2024",
            "news_id": "bca9021e-503e-4784-afec-4b29457dac62",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=114f388a-8088-41a1-8583-04981eed3038.pdf",
            "news_date": "2024-05-03 16:37:33",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earning Call transcript",
            "news_id": "ac7aa5df-0985-4e10-8be3-f5785edf52f3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=809936e1-5c06-4b69-903a-f870d0754cf9.pdf",
            "news_date": "2024-02-01 19:09:18",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Q3 & 9M FY24 Investor Presentation",
            "news_id": "dbe03b77-80a1-48b5-8be7-73e8a51d941d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e26594e4-af29-4245-8233-c62c1004c943.pdf",
            "news_date": "2024-01-24 19:19:26",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Standalone And Consolidated Financial Results For The Quarter And Nine Months Ended December 31, 2023.",
            "news_body": "Audited Standalone and Consolidated Financial Results for the quarter and nine months ended December 31, 2023",
            "news_id": "8788bed6-27fd-4724-8a5b-3fd90ca339f2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f2ade16d-e9b5-47fd-b15e-24635ec4fdd4.pdf",
            "news_date": "2024-01-24 16:02:35",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of earning call for Q2 & H1 FY24",
            "news_id": "8ed426b3-0302-4263-a51d-30f83975b62e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=91d689bc-6948-4c14-bee3-a0f6bc0affb1.pdf",
            "news_date": "2023-10-27 21:29:40",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Q2 & H1 FY24 Investor Presentation",
            "news_id": "4a75d9d7-f548-403c-90de-fb05c3552fba",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=01c84402-aa9b-4263-8cbe-5ef7a3deb822.pdf",
            "news_date": "2023-10-19 18:23:37",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter And Half Year Ended September 30, 2023",
            "news_body": "Financial Results for the quarter and half year ended September 30, 2023",
            "news_id": "387559a5-e23a-4738-b529-b0848107dfd9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3f81b5fd-115b-4a76-9098-f755c625d8a4.pdf",
            "news_date": "2023-10-19 16:00:17",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Presentation to the shareholders at the 38th Annual General Meeting",
            "news_id": "3663a061-64a1-418d-a5c5-66a97f79f1a0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=56c46cb6-18b8-46e9-a4a4-8cf689c836aa.pdf",
            "news_date": "2023-09-26 20:53:24",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Q1 FY24 Earning Conference Call",
            "news_id": "9794b82e-d3f3-47f7-a218-757db0febd5b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=01d281eb-7463-4082-836f-dc25cce40082.pdf",
            "news_date": "2023-07-28 20:40:57",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of earning call on the financial results for the quarter ended June 30, 2023",
            "news_id": "8cec73e1-722d-4134-a393-cb56ae41db26",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c47b8c67-c16a-4f8f-bf6a-9ed33d3d1fe4.pdf",
            "news_date": "2023-07-24 21:32:37",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find attached herewith Q1FY24 Investor Presentation",
            "news_id": "84b8d1f2-a813-4752-9806-c33d1025ceef",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9d72a2a0-f6a0-4699-ab8c-1b69c2d930fa.pdf",
            "news_date": "2023-07-21 19:42:49",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter Ended June 30, 2023",
            "news_body": "Financial Results for the quarter ended June 30, 2023",
            "news_id": "61e2f693-06f3-429d-ad66-7e7dcb6a0233",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9e7454c0-6860-4999-990c-91711231602b.pdf",
            "news_date": "2023-07-21 16:42:49",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Q4 FY23 Earning Conference Call",
            "news_id": "f7382ff2-611c-404c-87ad-16d32d8222fd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=451054ed-52d2-4da1-b754-10992cb9d2b0.pdf",
            "news_date": "2023-05-07 23:23:04",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Q4FY23 Results presentation",
            "news_id": "cb620984-eec8-4a8b-888e-3c70ba318c9f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=52b86931-cda4-48e2-80ec-ef6a05448d5d.pdf",
            "news_date": "2023-05-02 11:22:23",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Standalone And Consolidated Financial Results For The Quarter And Year Ended March 31, 2023",
            "news_body": "Audited Standalone and Consolidated Financial Results for the Quarter and Year ended March 31, 2023",
            "news_id": "78ab5201-94f5-43aa-bebb-e1fb8f7193b3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=51da8fbb-09eb-4309-a103-925f144bb886.pdf",
            "news_date": "2023-04-29 18:50:34",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find attached herewith Q3FY23 Results presentation of the Company for your records.",
            "news_id": "24039f1c-46e8-4b04-a222-bd8fd248149a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=de8b282b-30de-4494-8a47-ee392d53f560.pdf",
            "news_date": "2023-01-27 18:37:18",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Standalone And Consolidated Financial Results For The Quarter And Nine Months Ended December 31, 2022.",
            "news_body": "Audited Standalone and Consolidated Financial Results for the Quarter and Nine months ended December 31, 2022.",
            "news_id": "f5837ef5-ccde-48c5-bd0c-15fc40576b79",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dbea37d2-4cca-4df8-b8ca-7026d3e5c4c1.pdf",
            "news_date": "2023-01-27 16:43:58",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Compliance Under Regulation 23(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015.",
            "news_body": "Compliance under Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.",
            "news_id": "f396d0ce-1dc0-4258-b3b8-4dd290c0aae3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ccac31db-acff-46b4-8062-36675ae8e280.pdf",
            "news_date": "2022-11-02 19:56:03",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find attached herewith Q2FY23 Results presentation of the Company for your records.",
            "news_id": "b961e3d1-72a3-4989-a7c0-b6c46de96b32",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=257c9cfe-2aab-4f53-a6cc-1e49a4aa0f2e.pdf",
            "news_date": "2022-10-20 20:41:25",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Quarter And Half Year Ended September 30, 2022",
            "news_body": "Audited Financial Results for the Quarter and half Year ended September 30, 2022",
            "news_id": "ba5c067f-a334-4f96-b726-534e154853f4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=869c8deb-bd20-4f39-9409-d16e10256823.pdf",
            "news_date": "2022-10-20 15:35:57",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find attached herewith presentation made to the shareholders of the Company at the 37th Annual General Meeting held today i.e. August 4, 2022 for your records.",
            "news_id": "5851741b-bdce-46c5-bac8-fef7a91f9b45",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=453161b8-6171-4d14-8079-d4c8abe161a8.pdf",
            "news_date": "2022-08-04 19:59:55",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find attached herewith transcript of Q1 FY23 Earning Conference call.",
            "news_id": "7780a4d8-f566-4e60-ac8a-128fd6e28c4c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9ee1afeb-1b0e-4634-ae51-e79a810ac242.pdf",
            "news_date": "2022-08-03 23:04:39",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Recording Of Conference Call",
            "news_body": "In continuation to our letter dated July 22, 2022 regarding intimation of Investors/ Analyst conference call on the Financial Results of the Company for the quarter ended June 30, 2022, we would like to inform you that the audio recording of the said call has been uploaded on the Company's website.",
            "news_id": "4a69ce70-6888-4d02-846f-ca37bfd2b304",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1c270be0-688a-4f88-b2b0-49b23134c9e6.pdf",
            "news_date": "2022-07-28 21:17:20",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find attached herewith revised Q4FY22 Results presentation of the Company for your records. Changes have been made in slide number 8, 9, 11 and 13.",
            "news_id": "c0c9e23a-adde-4e83-8f21-e39603d49e54",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6e701036-9288-44a3-8902-ca81ab21cb0d.pdf",
            "news_date": "2022-06-07 18:15:17",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Compliance Under Regulation 23(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015.",
            "news_body": "In terms of Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose disclosure of Related Party Transactions in the format specified under SEBI Circular bearing reference no. SEBI/HO/CFD/CMD1/CIR/P/2021/662 dated November 22, 2021, for the half year ended March 31, 2022.",
            "news_id": "a96afd46-da0d-47e9-9280-b2ccd7f51a3b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c7c9e74c-ec24-4f16-8442-f135a2d69df2.pdf",
            "news_date": "2022-05-24 19:24:30",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find attached herewith transcript of Q4 FY22 Earning Conference call.",
            "news_id": "018ed899-25a5-4f02-97bc-34e0bc9bfe30",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=823d8383-f59b-4c82-8031-617b76d2a19c.pdf",
            "news_date": "2022-05-16 20:33:46",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Recording Of Conference Call",
            "news_body": "In continuation to our letter dated May 5, 2022 regarding intimation of Investors/ Analyst conference call on the Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31, 2022, we would like to inform you that the audio recording of the said call has been uploaded on the Company's website. This can be accessed via the following link. Link: https://www.aartidrugs.co.in/concalls-transcript/",
            "news_id": "c6ca5207-5d6e-429d-a9ed-4926cd1b64bf",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=21fff3a1-a063-4bc0-a322-3fdf0af29653.pdf",
            "news_date": "2022-05-10 20:00:29",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find attached herewith Q4FY22 Results presentation of the Company for your records.",
            "news_id": "6add4d01-6ebe-4e43-8616-55184285ad3c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=be1b7ec6-c9c8-49a2-b3bf-f14742a433d5.pdf",
            "news_date": "2022-05-09 19:44:41",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results Of The Company (Standalone And Consolidated) For The Quarter And Year Ended March 31, 2022",
            "news_body": "We wish to inform you that Board of Directors at its Meeting held on Monday, May 9, 2022, approved the Audited Financial Results of the Company (Standalone and Consolidated) for the Quarter and Year ended March 31, 2022. In this regards we enclose;<BR> i. Statement showing the Financial Results (Standalone and Consolidated),<BR> ii. Statement of Assets and Liabilities (Standalone and Consolidated),<BR> iii. Cash Flow Statement (Standalone and Consolidated)<BR> iv. Auditor's Report on the Financial Results (Standalone and Consolidated),<BR> v. Declaration in respect of Audit reports with unmodified opinion for the Financial Year ended March 31, 2022<BR>",
            "news_id": "679d181a-bfee-4009-afdf-a712e77df495",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d80f3fb1-2869-4961-9340-511dd0071d33.pdf",
            "news_date": "2022-05-09 15:42:52",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find attached herewith transcript of Q3 FY22 Earning Conference call.",
            "news_id": "668d427e-ebe4-44eb-9d06-161607bbc684",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d13cca0b-cf46-41fb-a8a6-f8f7176da2f1.pdf",
            "news_date": "2022-02-14 19:03:32",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find attached herewith Q3FY22 Results presentation of the Company for your records.",
            "news_id": "b84b91c7-7cde-4835-8d3d-dfee5a4868ee",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2ec63de6-80dd-451d-ba95-454edfd8b85e.pdf",
            "news_date": "2022-01-31 23:19:45",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Standalone And Consolidated Financial Results For The Quarter And Nine Months Ended December 31, 2021.",
            "news_body": "We wish to inform you that Board of Directors at its Meeting held on Monday, January 31, 2022, approved the Audited Standalone and Consolidated Financial Results for the Quarter and Nine months ended December 31, 2021.<BR> Pursuant to Regulation 33 of the SEBI (LODR) Regulations, 2015 we enclose the following:-<BR>   Audited Standalone and Consolidated Financial Results for the Quarter and Nine months ended December 31, 2021.<BR>   Auditor's Report on Standalone and Consolidated Financial Results for the Quarter and Nine months ended December 31, 2021.",
            "news_id": "f00b8733-a1cb-4404-af02-094a4641dbc5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9495b6b2-21ff-4e02-8d5d-ab10e92f593c.pdf",
            "news_date": "2022-01-31 15:12:40",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find attached herewith transcript of Q2 FY22 Earning Conference Call.",
            "news_id": "32a9be63-319f-4bb0-8f59-d78b6c4eb903",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=73d2a789-50e0-4e6d-be3c-e60a66d443b4.pdf",
            "news_date": "2021-11-15 20:36:06",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclosed herewith Results Presentation for the Quarter and half year ended September 30, 2021 for your records.",
            "news_id": "b04957cd-d1de-465a-bd7f-75099d7b2e8f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8182644c-ab76-43a8-8361-97c72a757ec0.pdf",
            "news_date": "2021-10-27 21:23:36",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended September 30, 2021",
            "news_body": "We wish to inform you that Board of Directors at its Meeting held on Wednesday, October 27, 2021, approved the Audited Standalone and Consolidated Financial Results for the Quarter and Half year ended September 30, 2021.<BR> Pursuant to Regulation 33 of the SEBI (LODR) Regulations, 2015 we enclose the following:-<BR>   Audited Standalone and Consolidated Financial Results for the Quarter and Half year ended September 30, 2021.<BR>   Standalone and Consolidated Statement of Assets and Liabilities.<BR>   Standalone and Consolidated Cash Flow Statement. <BR>   Auditor's Report on Standalone and Consolidated Financial Results for the Quarter and Half year ended September 30, 2021.<BR> <BR> Further, please note that the Company has already made necessary arrangement to publish the same in the Newspapers as required under the SEBI (LODR) Regulations, 2015.",
            "news_id": "1cae350d-7976-4be1-b4a8-4bf78e057306",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5a908dbf-ff0a-483d-9f8b-b83389f62758.pdf",
            "news_date": "2021-10-27 15:50:34",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find attached herewith transcript of Q1 FY22 Earning Conference Call.",
            "news_id": "159328c9-c816-437b-9021-3580d79861e5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6e01c29d-03e9-4d09-8fbd-5be8e1750297.pdf",
            "news_date": "2021-08-31 23:17:31",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclosed herewith Results Presentation for the Quarter ended June 30, 2021 for your records.",
            "news_id": "c38a9585-e557-428e-83ec-8c68d722a1fe",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d7a6e1f2-8c8d-486e-8109-701db7890b58.pdf",
            "news_date": "2021-07-28 14:51:46",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Standalone And Consolidated Financial Results For The Quarter Ended June 30, 2021.",
            "news_body": "We wish to inform you that Board of Directors at its Meeting held on Tuesday, July 27, 2021, approved the Audited Standalone and Consolidated Financial Results for the Quarter ended June 30, 2021.",
            "news_id": "b58f0b65-1b7f-46f6-98a6-89fc2f1aa21a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d345ba37-8d85-44c6-a080-d02affc7d027.pdf",
            "news_date": "2021-07-27 18:23:26",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions For Half Year Ended March 31, 2021",
            "news_body": "In compliance with Regulation 23(9) of SEBI (LODR) Regulations, 2015 we enclose disclosure of Related Party Transactions on a consolidated basis for the half year ended March 31, 2021.",
            "news_id": "35d61276-f471-46f7-acaa-e01b5157d7a6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5bbec15d-e2c8-4681-b291-a35b73482414.pdf",
            "news_date": "2021-06-13 15:42:20",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find attached herewith transcript of Q4 FY21 Earning Conference Call.",
            "news_id": "e9a5c6a7-0539-4060-af6c-a6235fcadb7d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5f27914f-33c1-45f9-891e-d89fc4caefe2.pdf",
            "news_date": "2021-06-09 13:58:30",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclosed herewith Results Presentation for the Quarter and year ended March 31, 2021 for your records.",
            "news_id": "95e869ae-e780-4683-8ce9-0d5d8507d592",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3956f80c-600b-4bd9-9f9f-c3539486b35c.pdf",
            "news_date": "2021-05-17 15:32:09",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "AARTIDRUGS",
            "disp": "Aarti Drugs",
            "bse_code": 524348,
            "isin": "INE767A01016",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Standalone And Consolidated Financial Results For The Quarter And Year Ended March 31, 2021",
            "news_body": "We wish to inform you that Board of Directors at its Meeting held on Saturday, May 15, 2021, approved the Audited Standalone and Consolidated Financial Results for the Quarter and Year ended March 31, 2021",
            "news_id": "9645b94b-9ede-4813-bbcd-cc28e12bc274",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=021b9e6c-750d-4ed7-b76b-131b4e75c219.pdf",
            "news_date": "2021-05-15 14:47:04",
            "seo": "aarti-drugs-ltd",
            "ltp": 375.25,
            "ch": -4.25,
            "pch": -1.1198945981554678,
            "inst": "EQUITY",
            "ts": 0.05,
            "ls": 1,
            "mtp": 1,
            "sid": 4481,
            "exch": "NSE",
            "seg": "E"
        }
    ]
}